Traditionally, intertumour heterogeneity in breast cancer has been documented in terms of
different histological subtypes, treatment sensitivity profiles, and clinical outcomes among …

Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is
therapeutically challenging and aggressive. MpBC is defined by the histological presence of …

PURPOSE Triple-negative breast cancer (TNBC) is considered aggressive, and therefore,
virtually all young patients with TNBC receive (neo) adjuvant chemotherapy. Increased …

The clinical outcomes and therapeutic strategies for infiltrating ductal carcinoma (IDC) and
infiltrating lobular carcinoma (ILC) are not uniform. The primary objectives of this study were …

Metaplastic breast carcinoma (MpBC) is a rare special histologic subtype of breast
carcinoma characterized by the presence of squamous and/or mesenchymal differentiation …

Purpose: The impact of different local therapy approaches on local control, event-free
survival, and secondary malignancies in the CESS 81, CESS 86, and EICESS 92 trials was …

Purpose: Metaplastic breast carcinoma (MBC) is a rare and aggressive histologic type of
breast cancer, predominantly of triple-negative phenotype, and characterized by the …

Metaplastic breast cancer (MpBC) is an uncommon aggressive malignancy that is
associated with a poor prognosis. Due to its rarity, the relationships between the clinical and …

Background Metaplastic breast cancer (MBC) is characterized by chemoresistance and
hematogenous spread. We sought to identify factors associated with improved MBC …

Squamous cell carcinoma (SCC) and adenocarcinoma (AC) are two main histological
subtypes of solid cancer; however, SCCs are derived from different organs with similar …